Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Keryer Bibens, Cécile ^a   Pioche Durieu, Catherine ^a   Villemant, Cécile ^a   Souquère, Sylvie ^b   Nishi, Nozomu ^c   Hirashima, Mitsuomi ^c   Middeldorp, Jaap ^d   Busson, Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT ANDRÉ LWOFF   (France)

^c KAGAWA UNIVERSITY   (Japan)

^d Amsterdam Gastroenterology Metabolism   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GALECTIN; HLA ANTIGEN CLASS 2; LATENT MEMBRANE PROTEIN 1;

ARTICLE; CARCINOMA CELL; CELL CULTURE; CENTRIFUGATION; CONTROLLED STUDY; CROSS LINKING; CULTURE MEDIUM; ELECTRON MICROSCOPY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EXOSOME; FRACTIONATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NASOPHARYNX CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PURIFICATION; T LYMPHOCYTE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; EXOCYTOSIS; GALECTINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; NASOPHARYNGEAL NEOPLASMS; RECOMBINANT PROTEINS; TRANSPORT VESICLES; VIRAL MATRIX PROTEINS;

EID: 33846864645     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-283     Document Type: Article

References (41)

1. Busson P Keryer C Ooka T Corbex M EBV-associated nasopharyngeal carcinomas: From epidemiology to virus-targeting strategies Trends Microbiol 2004 12 356-360 10.1016/j.tim.2004.06.005 15276610
2. Devi BC Pisani P Tang TS Parkin DM High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island Cancer Epidemiol Biomarkers Prev 2004 13 482-486 15006927
3. Nicholls JM Agathanggelou A Fung K Zeng X Niedobitek G The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma J Pathol 1997 183 164-168 10.1002/ (SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J 9390028
4. Busson P Braham K Ganem G Thomas F Grausz D Lipinski M Wakasugi H Tursz T Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha Proc Natl Acad Sci U S A 1987 84 6262-6266 299051 2819868 10.1073/pnas.84.17.6262
5. Huang YT Sheen TS Chen CL Lu J Chang Y Chen JY Tsai CH Profile of cytokine expression in nasopharyngeal carcinomas: A distinct expression of interleukin 1 in tumor and CD4+ T cells Cancer Res 1999 59 1599-1605 10197635
6. Tang KF Tan SY Chan SH Chong SM Loh KS Tan LK Hu H A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: Implication for the intense tumor infiltration by T lymphocytes and macrophages Hum Pathol 2001 32 42-49 10.1053/hupa.2001.20886 11172294
7. Teichmann M Meyer B Beck A Niedobitek G Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma J Pathol 2005 206 68-75 10.1002/path.1745 15751051
8. Raab-Traub N Epstein-Barr virus and the Pathogenesis of NPC Epstein-Barr virus Norfolk, Caister Robertson ES 2005 71-92
9. Heussinger N Buttner M Ott G Brachtel E Pilch BZ Kremmer E Niedobitek G Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma J Pathol 2004 203 696-699 10.1002/path.1569 15141385
10. Seto E Yang L Middeldorp J Sheen TS Chen JY Fukayama M Eizuru Y Ooka T Takada K Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression J Med Virol 2005 76 82-88 10.1002/ jmv.20327 15778977
11. Munz C Epstein-barr virus nuclear antigen 1: From immunologically invisible to a promising T cell target J Exp Med 2004 199 1301-1304 10.1084/jem.20040730 15148332
12. Lee SP Chan AT Cheung ST Thomas WA CroomCarter D Dawson CW Tsai CH Leung SF Johnson PJ Huang DP CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells J Immunol 2000 165 573-582 10861098
13. Whitney BM Chan AT Rickinson AB Lee SP Lin CK Johnson PJ Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients J Med Virol 2002 67 359-363 10.1002/jmv.10073 12116028
14. Dukers DF Meij P Vervoort MB Vos W Scheper RJ Meijer CJ Bloemena E Middeldorp JM Direct immunosuppressive effects of EBV-encoded latent membrane protein 1 J Immunol 2000 165 663-670 10878338
15. Flanagan J Middeldorp J Sculley T Localization of the Epstein-Barr virus protein LMP 1 to exosomes J Gen Virol 2003 84 1871-1879 10.1099/ vir.0.18944-0 12810882
16. Pioche-Durieu C Keryer C Souquere S Bosq J Faigle W Loew D Hirashima M Nishi N Middeldorp J Busson P In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin J Virol 2005 79 13326-13337 1262583 16227255 10.1128/JVI.79.21.13326-13337.2005
17. Tureci O Schmitt H Fadle N Pfreundschuh M Sahin U Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease J Biol Chem 1997 272 6416-6422 10.1074/jbc.272.10.6416 9045665
18. Kashio Y Nakamura K Abedin MJ Seki M Nishi N Yoshida N Nakamura T Hirashima M Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway J Immunol 2003 170 3631-3636 12646627
19. Dai SY Nakagawa R Itoh A Murakami H Kashio Y Abe H Katoh S Kontani K Kihara M Zhang SL Hata T Nakamura T Yamauchi A Hirashima M Galectin-9 induces maturation of human monocyte-derived dendritic cells J Immunol 2005 175 2974-2981 16116184
20. Zhu C Anderson AC Schubart A Xiong H Imitola J Khoury SJ Zheng XX Strom TB Kuchroo VK The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat Immunol 2005 6 12 1245-52 10.1038/ni1271 16286920
21. Hirashima M Kashio Y Nishi N Yamauchi A Imaizumi TA Kageshita T Saita N Nakamura T Galectin-9 in physiological and pathological conditions Glycoconj J 2004 19 593-600 10.1023/B:GLYC.0000014090.63206.2f 14758084
22. Perone MJ Larregina AT Shufesky WJ Papworth GD Sullivan ML Zahorchak AF Stolz DB Baum LG Watkins SC Thomson AW Morelli AE Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells J Immunol 2006 176 7207-7220 16751364
23. Thery C Boussac M Veron P Ricciardi-Castagnoli P Raposo G Garin J Amigorena S Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles J Immunol 2001 166 7309-7318 11390481
24. Busson P Ganem G Flores P Mugneret F Clausse B Caillou B Braham K Wakasugi H Lipinski M Tursz T Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas Int J Cancer 1988 42 599-606 2971626
25. Sbih-Lammali F Clausse B Ardila-Osorio H Guerry R Talbot M Havouis S Ferradini L Bosq J Tursz T Busson P Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation Cancer Res 1999 59 924-930 10029086
26. Rowe M Evans HS Young LS Hennessy K Kieff E Rickinson AB Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells J Gen Virol 1987 68 (Pt 6) 1575-1586 2438376
27. Pelletier I Hashidate T Urashima T Nishi N Nakamura T Futai M Arata Y Kasai K Hirashima M Hirabayashi J Sato S Specific recognition of Leishmania major poly-beta-galactosyl epitopes by galectin-9: Possible implication of galectin-9 in interaction between L. major and host cells J Biol Chem 2003 278 22223-22230 10.1074/jbc.M302693200 12684513
28. Palacios R Monoclonal antibodies against human Ia antigens stimulate monocytes to secrete interleukin 1 Proc Natl Acad Sci U S A 1985 82 6652-6656 391268 3876560 10.1073/pnas.82.19.6652
29. Charrin S Le Naour F Oualid M Billard M Faure G Hanash SM Boucheix C Rubinstein E The major CD9 and CD81 molecular partner. Identification and characterization of the complexes J Biol Chem 2001 276 14329-14337 11278880
30. Meij P Vervoort MB Meijer CJ Bloemena E Middeldorp JM Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells J Virol Methods 2000 90 193-204 10.1016/S0166-0934(00)00233-0 11064119
31. Vicat JM Ardila-Osorio H Khabir A Brezak MC Viossat I Kasprzyk P Jlidi R Opolon P Ooka T Prevost G Huang DP Busson P Apoptosis and TRAF-1 cleavage in Epstein-Barr virus-positive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor Biochem Pharmacol 2003 65 423-433 10.1016/S0006-2952(02)01449-1 12527335
32. Thery C Zitvogel L Amigorena S Exosomes: Composition, biogenesis and function Nat Rev Immunol 2002 2 569-579 12154376
33. Hugel B Martinez MC Kunzelmann C Freyssinet JM Membrane microparticles: two sides of the coin Physiology (Bethesda) 2005 20 22-27 15653836
34. Taylor DD Gercel-Taylor C Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects Br J Cancer 2005 92 305-311 15655551
35. Khanna R Busson P Burrows SR Raffoux C Moss DJ Nicholls JM Cooper L Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells Cancer Res 1998 58 310-314 9443410
36. Ho SY Guo HR Chen HH Hsiao JR Jin YT Tsai ST Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma Head Neck 2004 26 977-983 10.1002/hed.20090 15390195
37. Beck A Pazolt D Grabenbauer GG Nicholls JM Herbst H Young LS Niedobitek G Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: Comparison with Hodgkin's disease J Pathol 2001 194 145-151 10.1002/path.867 11400141
38. Ozyar E Ayhan A Korcum AF Atahan IL Prognostic role of Epstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma Cancer Invest 2004 22 483-491 10.1081/CNV-200026386 15565804
39. Tsukuda M Sawaki S Yanoma S Suppressed cellular immunity in patients with nasopharyngeal carcinoma J Cancer Res Clin Oncol 1993 120 115 118 10.1007/BF01200735 8270600
40. Zanussi S Vaccher E Caffau C Pratesi C Crepaldi C Bortolin MT Tedeschi R Politi D Barzan L Tirelli U De Paoli P Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type Cancer Immunol Immunother 2003 52 28-32 12536237
41. Delsol G Brousset P Chittal S Rigal-Huguet F Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease Am J Pathol 1992 140 247-253 1310829